Dr. Guerrero-Miranda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3410 Worth St
Ste 545
Dallas, TX 75246Phone+1 214-820-7068Fax+1 214-820-1474
Summary
- Dr. Cesar Guerrero-Miranda is a cardiologist in Dallas, TX and is affiliated with Baylor University Medical Center. He received his medical degree from Cayetano Heredia University and has been in practice 13 years. He specializes in advanced heart failure, cardiogenic shock, mechanical circulatory support and transplantation and is experienced in general cardiology, echocardiography, and heart failure and transplantation.
Education & Training
- Montefiore Medical Center/Albert Einstein College of Medicine (Montefiore)Fellowship, Cardiovascular Disease, 2013
- Rutgers Health/Newark Beth Israel Medical CenterFellowship, Advanced Heart Failure and Transplant Cardiology, 2011 - 2013
- University of Miami/Jackson Health SystemResidency, Internal Medicine, 2008 - 2011
- Cayetano Heredia UniversityClass of 2004
Certifications & Licensure
- TX State Medical License 2016 - 2025
- NJ State Medical License 2011 - 2013
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Mechanical Circulatory Support National Fellows Course Scholarship St. Jude, 2015
- Henry I. Russek Travel Award American College of Cardiology (ACC), 2015
- Minority High School Program American Heart Association (AHA), 2015
- Join now to see all
Publications & Presentations
PubMed
- Three-year outcomes of de novo tacrolimus extended-release tablets (LCPT) compared to twice-daily tacrolimus in adult heart transplantation.Amit Alam, Johanna S van Zyl, Raksha Patel, Aayla K Jamil, Joost Felius
Transplant Immunology. 2024-04-01 - HeartMate 3 Explantation Using Felt Plug for Ventriculotomy Occlusion.Melissa Medina, Amit Alam, Amarinder Bindra, Nishi Patel, Cesar Guerrero-Miranda
Methodist Debakey Cardiovascular Journal. 2023-01-01 - 14 citationsManagement of cardiac diseases in liver transplant recipients: Comprehensive review and multidisciplinary practice-based recommendations.Manhal Izzy, Brett E Fortune, Marina Serper, Nicole Bhave, Andrew deLemos
American Journal of Transplantation. 2022-12-01
Journal Articles
- Antiplatelet Therapy and Adverse Hematological Events during Heart Mate II SupportO. Saeed, A. Shah, F. Kargoli, A. Levin, S. Patel, R. Jermyn, C.Y. Guerrero Miranda, J. Nguyen, D. Sims, J. Shin, D. D’Alessandro, D. Goldstein, U. Jorde, Circ Heart Fail, 1/1/2016
Abstracts/Posters
- Non-invasive Endothelial Dysfunction Evaluation Through Flow-Dependent Vasodilation of the Brachial Artery Measured by Ultrasound in Controlled and non-Controlled Hype...C.Y. Guerrero-Miranda, F. Medina, F. Samalvides, VI International Congress of Cardiology, San Pablo Clinic, Lima, Peru, 1/1/2004
- Detection of Mycobacterium Tuberculosis Through Polymerase Chain Reaction (PCR) in Patients with Tuberculous Pericarditis. Diagnostic Test ValidationC.Y. Guerrero-Miranda, J. Rossell, VI International Congress of Cardiology, San Pablo Clinic, Lima, Peru, 1/1/2004
Lectures
- Rate Responsive Pacing Improves Aerobic Exercise Capacity and 6 min Walk in CF-LVAD PatientsWashington, DC - 1/1/2016
- Rate Responsive Pacing Improves Aerobic Exercise Capacity and 6 min Walk in CF-LVAD PatientsWashington, DC - 1/1/2016
- Prevalence and Correlation of Non Functional Tricuspid Regurgitation to Right Ventricular Failure in Patients with CF-LVADsNational Harbor, MD - 1/1/2015
- Join now to see all
Press Mentions
- Natriuretic Peptides: Do They Inform the Potential for Treatment Response in HFpEF?∗November 9th, 2022
- Potential Interactions When Prescribing SGLT2 Inhibitors and Intravenous Iron in Combination in Heart FailureNovember 5th, 2022
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: